CRIS Current Research Information System

DEL GAUDIO, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.396
EU - Europa 6.092
AS - Asia 5.151
AF - Africa 569
SA - Sud America 328
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.550
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.330
SG - Singapore 1.678
CN - Cina 1.403
GB - Regno Unito 1.150
DE - Germania 1.036
VN - Vietnam 914
IT - Italia 909
NL - Olanda 846
SE - Svezia 681
HK - Hong Kong 462
IN - India 374
RU - Federazione Russa 276
UA - Ucraina 256
BR - Brasile 245
FR - Francia 236
IE - Irlanda 222
CI - Costa d'Avorio 213
TG - Togo 136
FI - Finlandia 103
ZA - Sudafrica 90
EE - Estonia 84
KR - Corea 82
SC - Seychelles 74
CH - Svizzera 70
BG - Bulgaria 64
JP - Giappone 60
AR - Argentina 45
NG - Nigeria 44
JO - Giordania 42
CA - Canada 41
BE - Belgio 27
AT - Austria 26
IR - Iran 24
ES - Italia 21
MX - Messico 18
PL - Polonia 18
ID - Indonesia 16
EC - Ecuador 15
BD - Bangladesh 12
TR - Turchia 12
RO - Romania 11
PH - Filippine 10
UZ - Uzbekistan 10
AU - Australia 9
MK - Macedonia 9
PK - Pakistan 9
IQ - Iraq 8
LT - Lituania 8
GR - Grecia 6
HR - Croazia 6
DK - Danimarca 5
LB - Libano 5
PY - Paraguay 5
SA - Arabia Saudita 5
CL - Cile 4
CO - Colombia 4
CZ - Repubblica Ceca 4
EG - Egitto 4
PE - Perù 4
PT - Portogallo 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
LK - Sri Lanka 3
MA - Marocco 3
MY - Malesia 3
NO - Norvegia 3
AZ - Azerbaigian 2
CR - Costa Rica 2
IL - Israele 2
LU - Lussemburgo 2
MM - Myanmar 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
VE - Venezuela 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
ME - Montenegro 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 19.549
Salva come PNG Salva come JPEG
Città #
Singapore 1.118
Southend 1.001
Ashburn 813
Chandler 770
Fairfield 751
Kerkrade 651
Hong Kong 460
Frankfurt am Main 373
Dong Ket 361
Woodbridge 359
Wilmington 356
Santa Clara 290
Seattle 287
Houston 285
Princeton 274
Cambridge 235
Dublin 222
Ann Arbor 216
Abidjan 212
Hefei 187
Beijing 182
Boardman 160
Jacksonville 156
Dallas 146
Bologna 145
Ho Chi Minh City 141
Lomé 136
Nanjing 109
Los Angeles 105
Westminster 103
Hanoi 97
Padova 93
Berlin 82
Seoul 79
Munich 77
Helsinki 74
Milan 73
New York 64
Saint Petersburg 63
Sofia 61
Jinan 59
Bern 57
Buffalo 57
Florence 57
Tokyo 57
Shenyang 52
Redmond 46
Abeokuta 43
Amman 42
San Diego 40
Dearborn 39
Redondo Beach 39
Turin 38
São Paulo 37
Delhi 36
Hebei 36
Nanchang 34
Rome 33
Des Moines 32
Falkenstein 32
Guangzhou 32
Medford 32
Tianjin 28
Mülheim 27
Bremen 26
Brussels 26
Zhengzhou 26
Jiaxing 25
Changsha 24
Phoenix 24
Chicago 22
Turku 22
Redwood City 21
Düsseldorf 20
Hangzhou 19
London 19
Olalla 19
Shanghai 19
Haiphong 18
Nuremberg 18
Haikou 17
Norwalk 17
Hyderabad 16
Ningbo 16
Toronto 16
Mahé 15
Amsterdam 14
Bengaluru 14
Lanzhou 14
Mountain View 14
Kyiv 13
Lauterbourg 13
Potenza 13
San Francisco 13
Bühl 12
Council Bluffs 12
Falls Church 12
Vienna 12
Yubileyny 12
Biên Hòa 11
Totale 12.976
Salva come PNG Salva come JPEG
Nome #
[Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer] 1.214
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 287
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 286
TRAPIANTO DI FEGATO CON TROMBOSI PORTALE COMPLETA: ESPERIENZA DI 11 CASI TRATTATI MEDIANTE ANASTOMOSI TRA LA VENA PORTA DEL GRAFT E LA VARICE GASTRICA DEL RICEVENTE 284
A comprehensive analysis on expected years of life lost due to pancreatic cancer 278
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 271
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 264
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 240
A new liver transplant priority for patients with hepatocellular carcinoma. 236
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 220
Surgical therapy for hepatolithiasis: a Western experience. 216
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 214
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 199
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 196
Combined liver–dual kidney transplant: Role in expanded donors 195
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 192
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 191
Coping strategies in intestinal transplantation 190
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 190
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 185
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 185
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 184
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 183
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 179
Efficacy of MELD score in predicting survival after liver retransplantation. 178
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 177
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 175
Using Elderly Donors in Liver Transplantation. 174
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 172
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 171
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 170
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 170
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 170
Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation 170
Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST 169
Incidence, clinical significance, and outcome of vascular alterations in intestinal biopsies after isolated small bowel transplantation: a single-center experience. 163
Induction therapy with Alemtuzumab (Campath) in combined liver-kidney transplantation: University of Bologna experience. 161
Ruolo della linfadenectomia in corso di epatectomia per metastasi colorettali. 160
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 160
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 159
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation. 156
Kidney preservation: review of present and future perspective. 153
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 153
Medication compliance after liver transplantation: the importance of family support 152
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 152
Hypothermic oxygenated perfusion versus static cold storage for expanded criteria donors in liver and kidney transplantation: Protocol for a single-center randomized controlled trial 151
Outcome of hepatic artery reconstruction in liver transplantation with an iliac arterial interposition graft. 151
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases. 150
DOPPI TRAPIANTI DI RENE MONOLATERALI CON RICOSTRUZIONI VASCOLARI A BANCO IN GRFAFT CON VASI MULTIPLI E RICEVENTI SEVERAMENTE ATEROMASICI 150
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 150
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 149
Liver tissue: a proof-of-concept study for OLT in MNGIE patients 149
Hypothermic oxygenated perfusion in extended criteria donor liver transplantation-A randomized clinical trial 147
The role of liver resections for metastases from lung carcinoma. 146
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. 146
Long-term results after curative resection for carcinoma of the gallbladder according to the TNM stage 144
The role of liver resections for metastases from lung carcinoma 144
Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial. 144
Comparison between observed survival after resection of transplantable hepatocellular carcinoma and predicted survival after listing through a Markov model simulation. 144
Liver Transplantation With Left Lateral Segments in Adults: A Risk or a Possibility? 143
Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. 142
Liver metastases from non-gastrointestinal non-neuroendocrine tumours: review of the literature. 142
Recovery from liver dysfunction after adult isolated intestinal transplantation without liver grafting. 139
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. 138
RESISTENZA AL FLUSSO E MARKERS METABOLICI COME STRUMENTI DI VALUTAZIONE D’ORGANO PER IL TRAPIANTO DI RENI MARGINALI: STUDIO PROSPETTICO ITALIANO SULLA PERFUSIONE IPOTERMICA OSSIGENATA 138
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. 137
Hypothermic Oxygenated Perfusion in Extended Criteria Donor Kidney Transplantation-A Randomized Clinical Trial 135
null 135
The Relationship between Timing of Pretransplant Kidney Biopsy, Graft Loss, and Survival in Kidney Transplantation: An Italian Cohort Study 135
Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era 134
Twenty-five consecutive isolated intestinal transplants in adult patients: a five-yr clinical experience. 134
The role of liver surgery in the treatment of non-colorectal non-neuroendocrine metastases (NCRNNE). Analysis of 134 resected patients. 133
Double Single-Side Kidney Transplants With Bench Vascular Reconstruction: A Further Challenge Beyond the Marginality Without Future Preclusions 132
Sirolimus in liver transplant recipients: a large single-center experience. 132
Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS) 131
Long-term antiviral treatment for recurrent hepatitis C after liver transplantation. 131
HCV ED ETA' AVANZATA SONO LIMITI SUPERABILI NELLA DONAZIONE DI RENE DA VIVENTE 129
Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma? 128
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation. 127
Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. 126
MATCH DONATORE-RICEVENTE NEL TRAPIANTO DI FEGATO: COME MIGLIORARE LA SOPRAVVIVENZA NEI PAZIENTI CON MELD ELEVATO NELL'ERA DEI DONATORI MARGINALI 126
Prospective down-staging protocol for HCC not meeting the Milan criteria 125
Radical surgery for gallbladder carcinoma: possibilities of survival 124
Nested stromal-epithelial tumor (NSET) of the liver: A case report of an extremely rare tumor. 123
Surgical approach to complicated intestinal failure for benign disease in adult patients: transplantation or surgical rehabilitation? 122
DOWN-STAGING TREATMENT IMPROVEMENTS CHANGED THE PARADIGM OF LIVER TRANSPLANTATION FOR HCC 120
Successful Dual Kidney Transplantation After Hypothermic Oxygenated Perfusion of Discarded Human Kidneys 117
Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: is it necessary? 117
The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. 114
Impact of very advanced donor age on hepatic artery thrombosis after liver transplantation. 113
Improved diagnostic imaging and interventional therapies prolong survival after resection for hepatocellular carcinoma in cirrhosis: the university of bologna experience over 10 years. 113
LIVER TRANSPLANTATION IN RECIPIENTS WITH HISTORY OF AIDS-DEFINING CLINICAL CONDITIONS: IS IT POSSIBLE TO EXTEND THE INDICATIONS? 113
Preliminary experience of sequential use of normothermic and hypothermic oxygenated perfusion for donation after circulatory death kidney with warm ischemia time over the conventional criteria - a retrospective and observational study 112
Qualità di vita e benessere psicologico nel trapianto d'intestino 111
Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis 110
Liver and Vena Cava En Bloc Resection for an Invasive Leiomyosarcoma Causing Budd-Chiari Syndrome, Under Veno-Venous Bypass and Liver Hypothermic Perfusion : Liver Hypothermic Perfusion and Veno-Venous Bypass for Inferior Vena Cava Leiomyosarcoma 110
Reply 110
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE. 110
Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. 109
Liver transplantation with the Meld system: a prospective study from a single European center. 108
Totale 16.937
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.327
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.215 0 0 0 0 0 81 22 93 176 132 109 602
2021/20222.357 174 97 123 200 224 106 57 187 81 158 539 411
2022/20233.190 293 501 163 408 202 253 119 199 600 93 234 125
2023/2024814 75 164 57 78 58 137 41 42 16 59 41 46
2024/20253.362 177 468 272 296 447 171 231 110 54 296 195 645
2025/20264.616 604 636 669 493 790 1.424 0 0 0 0 0 0
Totale 19.870